These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A short form of gross motor function measure for Fukuyama congenital muscular dystrophy. Sato T, Adachi M, Matsuo A, Zushi M, Goto K, Hirose M, Ishiguro K, Shichiji M, Murakami T, Ikai T, Osawa M, Kondo I, Nagata S, Ishigaki K. Brain Dev; 2020 May; 42(5):383-388. PubMed ID: 32145987 [Abstract] [Full Text] [Related]
24. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F. Hum Mol Genet; 2003 Nov 01; 12(21):2853-61. PubMed ID: 12966029 [Abstract] [Full Text] [Related]
25. [Fukuyama-type congenital muscular dystrophy]. Toda T. Rinsho Shinkeigaku; 2000 Dec 01; 40(12):1297-9. PubMed ID: 11464484 [Abstract] [Full Text] [Related]
26. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK, Hewitt JE. Hum Mol Genet; 2003 Oct 15; 12 Spec No 2():R259-64. PubMed ID: 12925572 [Abstract] [Full Text] [Related]
27. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin. Yamamoto T, Kato Y, Kawaguchi M, Shibata N, Kobayashi M. Med Electron Microsc; 2004 Dec 15; 37(4):200-7. PubMed ID: 15614444 [Abstract] [Full Text] [Related]
31. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan. Xiong H, Kobayashi K, Tachikawa M, Manya H, Takeda S, Chiyonobu T, Fujikake N, Wang F, Nishimoto A, Morris GE, Nagai Y, Kanagawa M, Endo T, Toda T. Biochem Biophys Res Commun; 2006 Dec 01; 350(4):935-41. PubMed ID: 17034757 [Abstract] [Full Text] [Related]
33. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome. Toda T, Yoshioka M, Nakahori Y, Kanazawa I, Nakamura Y, Nakagome Y. Ann Neurol; 1995 Jan 01; 37(1):99-101. PubMed ID: 7818265 [Abstract] [Full Text] [Related]
37. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms]. Nonaka I. Nihon Rinsho; 1997 Dec 01; 55(12):3176-80. PubMed ID: 9436431 [Abstract] [Full Text] [Related]
38. [Clinical significance of serum cardiac myosin light chain I in patients with muscular dystrophy]. Saitoh M, Miyakoda H, Kitamura H, Kasagi S, Takakura H. Rinsho Shinkeigaku; 1990 Aug 01; 30(8):835-9. PubMed ID: 2253417 [Abstract] [Full Text] [Related]
39. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. Lim BC, Ki CS, Kim JW, Cho A, Kim MJ, Hwang H, Kim KJ, Hwang YS, Park WY, Lim YJ, Kim IO, Lee JS, Chae JH. Neuromuscul Disord; 2010 Aug 01; 20(8):524-30. PubMed ID: 20620061 [Abstract] [Full Text] [Related]
40. [Molecular genetics and merosin abnormality in Fukuyama-type congenital muscular dystrophy (FCMD)]. Toda T, Kobayashi K. Nihon Rinsho; 1997 Dec 01; 55(12):3169-75. PubMed ID: 9436430 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]